Difference between revisions of "TSC SWOT"

From HL7 TSC
Jump to navigation Jump to search
Line 1: Line 1:
 
*Strengths
 
*Strengths
 +
**Clear focus on delineated governance and management activities
 
** Respected, highly experienced membership
 
** Respected, highly experienced membership
 
** Committed membership
 
** Committed membership
 
** Support from board, HQ, and Work Group members
 
** Support from board, HQ, and Work Group members
** Responsive
+
** Open, transparent, and responsive
 
**Proactive
 
**Proactive
  
Line 12: Line 13:
 
*Opportunities
 
*Opportunities
 
** Linkage with Strategic Initiatives
 
** Linkage with Strategic Initiatives
** Establish and drive Product Strategy
+
**Business Architecture Model development offers improved Governance and Management to match existing Methodology strengths
 +
**Change to Intellectual Property licensing at no cost
 +
**Clearly designate our product line and product identification
 +
**Emergence of new and contemporary technology including FHIR and semantic web ontologies
 
**Improve Product Quality
 
**Improve Product Quality
  
 
*Threats
 
*Threats
 
** Creating overheads without visible return
 
** Creating overheads without visible return
** Unlicensed use of HL7 IP
+
**Change to Intellectual Property licensing at no cost
** Profiler/Enforcer creating their own healthcare interoperability standards
+
** Lack of confidence in standards management creates vacuum for Profiler/Enforcer creating their own healthcare interoperability standards
  
Approved by TSC 2010-12-20
+
Approved by TSC 2012-09-11

Revision as of 19:29, 19 September 2012

  • Strengths
    • Clear focus on delineated governance and management activities
    • Respected, highly experienced membership
    • Committed membership
    • Support from board, HQ, and Work Group members
    • Open, transparent, and responsive
    • Proactive
  • Weakness
    • Limited time
    • Limited control over resources
  • Opportunities
    • Linkage with Strategic Initiatives
    • Business Architecture Model development offers improved Governance and Management to match existing Methodology strengths
    • Change to Intellectual Property licensing at no cost
    • Clearly designate our product line and product identification
    • Emergence of new and contemporary technology including FHIR and semantic web ontologies
    • Improve Product Quality
  • Threats
    • Creating overheads without visible return
    • Change to Intellectual Property licensing at no cost
    • Lack of confidence in standards management creates vacuum for Profiler/Enforcer creating their own healthcare interoperability standards

Approved by TSC 2012-09-11